Αρχειοθήκη ιστολογίου

Πέμπτη 19 Απριλίου 2018

Antigen Presentation Keeps Trending in Immunotherapy Resistance

Through a gain-of-function kinome screen, MEX3B was identified as a mediator of resistance to T cell immunotherapy not previously identified using CRISPR based screens. MEX3B is a post-transcriptional regulator of HLA-A, validating the critical role of tumor-intrinsic antigen presentation in T cell immunotherapy and indicating a new putative molecular target.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader https://ift.tt/2K1bMGH

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου